Try our Advanced Search for more refined results

Deals Rumor Mill: Allergan, Credit Suisse, Alitalia

By Chelsea Naso (June 9, 2014, 4:57 PM EDT) -- Allergan Inc. shareholders have told activist investor Bill Ackman, who is trying to buy the Botox maker along with Valeant Pharmaceuticals International Inc., they would support a deal at $180 per share, Ackman said during an interview on CNBC. Ackman, who owns a nearly 10 percent stake in California-based Allergan through Pershing Square Capital Management, and Valeant, are currently in the middle of a hostile takeover battle for the Botox maker that started with a joint bid on April 22. Last week, Ackman outlined plans to oust a majority of directors at Allergan in an effort to force negotiations....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!